Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Soleno Therapeutics (SLNO) Retained Earnings: 2013-2018

Historic Retained Earnings for Soleno Therapeutics (SLNO) over the last 6 years, with Dec 2018 value amounting to -$127.0 million.

  • Soleno Therapeutics' Retained Earnings fell 12.48% to -$143.2 million in Q3 2019 from the same period last year, while for Sep 2019 it was -$143.2 million, marking a year-over-year decrease of 12.48%. This contributed to the annual value of -$127.0 million for FY2018, which is 11.73% down from last year.
  • Soleno Therapeutics' Retained Earnings amounted to -$127.0 million in FY2018, which was down 11.73% from -$113.7 million recorded in FY2017.
  • Soleno Therapeutics' 5-year Retained Earnings high stood at -$70.3 million for FY2014, and its period low was -$127.0 million during FY2018.
  • For the 3-year period, Soleno Therapeutics' Retained Earnings averaged around -$113.0 million, with its median value being -$113.7 million (2017).
  • Data for Soleno Therapeutics' Retained Earnings shows a maximum YoY fell of 23.18% (in 2014) over the last 5 years.
  • Yearly analysis of 5 years shows Soleno Therapeutics' Retained Earnings stood at -$70.3 million in 2014, then dropped by 22.62% to -$86.2 million in 2015, then dropped by 13.99% to -$98.3 million in 2016, then declined by 15.65% to -$113.7 million in 2017, then fell by 11.73% to -$127.0 million in 2018.